Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

NCT07645625 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT07645625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07645625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Recruiting
Start date
May 11, 2026
Completion date
February 28, 2039
Enrollment
261 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer